bpc 157 banned fda Banned: Key Facts on the Latest Decision bpc-157 purchase legal status FDA

Once reconstituted, handling should follow validated internal procedures for refrigerated use and limited stability windows

human clinical trials ongoing as of 2026 Search volume: 165,000 monthly US searches most searched non-weight-loss peptide Legal status: Category 1 compounding (legal under physician prescription, as of February 2026) Administration: Subcutaneous injection or oral/sublingual (gut applications) An honest note on the evidence: The majority of BPC-157 research has been conducted in animal models rats and mice primarily

10.1016/j.ejphar.2011.05.038 31 IlicS.DrmicD.ZarkovicK.KolencD.CoricM.BrcicL.et al (2010)

Yes, it is often utilized alongside other supportive treatments